Microarray Biochips Market Size to Grow by USD 14.75 Bn, Agilent Technologies Inc. and BioChain Institute Inc. Among Key Vendors - Technavio

NEW YORK, Oct. 31, 2022 /PRNewswire/ -- The microarray biochips market size is expected to grow by USD 14.75 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 19.95% during the forecast period, according to Technavio. The increase in market presence with a collaboration strategy is driving the microarray biochips market growth. However, factors such as capital-intensive markets may challenge market growth.

View a comprehensive report summary that describes the market size and forecast along with the research methodology. The FREE sample report is available in PDF format

The microarray biochips market report covers the following areas:

• Microarray Biochips Market size
• Microarray Biochips Market trends
• Microarray Biochips Market industry analysis

Subscribe to our "Basic Plan" billed annually at USD 5000 that enables you to download 5 reports and view 100 reports per month

We provide a detailed analysis of around 25 vendors operating in the Microarray Biochips Market, including Abbott Laboratories, Agilent Technologies Inc., Applied Microarrays Inc., Bio Rad Laboratories Inc., BioChain Institute Inc., BioIVT LLC, Biometrix Technology Inc., Danaher Corp., Fluidigm Corp., F. Hoffmann La Roche Ltd., HORIBA Ltd., General Electric Co., Merck KGaA, Illumina Inc., Pantomics Inc., OriGene Technologies Inc., Protein Biotechnologies Inc., PerkinElmer Inc., Randox Laboratories Ltd., QIAGEN NV, Thermo Fisher Scientific Inc., RayBiotech Life Inc., and bioMerieux SA. The key offerings of some of these vendors are listed below:

• Agilent Technologies Inc. - The company offers microarray biochips products such as Mouse Exon Microarrays.
• BioChain Institute Inc. - The company offers microarray biochips products such as BioChain human cDNA and BioChain genomic DNA.
• F. Hoffmann La Roche Ltd. - The company offers microarray biochips such as Cepheid Xpert MTB and Xpert EV.
• General Electric Co. - The company offers microarray biochips such as C1 Single-Cell Reagent Kit for Preamp, C1 Single-Cell Reagent Kit for mRNA Seq, and C1 Single-Cell mRNA Seq HT Reagent Kit v2 - 5 IFC.
• HORIBA Ltd. - The company offers microarray biochips such as DNAscan Rapid DNA Analysis System.

This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now to gain access to detailed vendor information

• Application 
• Drug discovery and development: The drug discovery and development segment will be a significant contributor to market growth during the forecast period. The growing use of microarray biochips in the field of genomics and proteomics will increase their demand during the forecast period. The rising preference for personalized medicines is also leading to the growth of this segment.
• Diagnostics and treatments
• Research and consumables
• Forensic medicines
• Others
• Geography 
• North America: North America will account for 39% of the market's growth during the forecast period. This growth is attributed to factors such as a well-developed infrastructure for medical research and studies of genomics and proteomics and disease outbreaks. The US is the key country for the microarray biochips market in North America.
• Europe
• Asia
• Rest Of World (ROW)

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

• CAGR of the market during 2022-2026
• Detailed information on factors that will assist microarray biochips market growth during the next five years
• Approximation of the microarray biochips market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the microarray biochips market
• Analysis of the competitive landscape and detailed information on vendors
• Comprehensive details of factors that will impede the growth of microarray biochips market vendors

Protein Microarray Market by Class Type and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by class type (analytical protein microarrays and functional protein microarrays) and geography (North America, Europe, Asia, and ROW). 38% of the market's growth will originate from North America during the forecast period. The protein microarray market share growth by the analytical protein microarray segment will be significant.

Tissue Microarray Market by End-user and Geography - Forecast and Analysis 2022-2026: This report extensively covers market segmentation by end-user (hospitals, clinics, and diagnostics centers) and geography (North America, Europe, Asia, and ROW). 36% of the market's growth will originate from North America during the forecast period. The tissue microarray market share growth by the hospital segment will be significant.

Browse Health Care Market Reports

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Drug discovery and development - Market size and forecast 2021-2026
• Exhibit 28: Chart on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Drug discovery and development - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Drug discovery and development - Year-over-year growth 2021-2026 (%)

• 5.4 Diagnostics and treatments - Market size and forecast 2021-2026
• Exhibit 32: Chart on Diagnostics and treatments - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Diagnostics and treatments - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Diagnostics and treatments - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Diagnostics and treatments - Year-over-year growth 2021-2026 (%)

• 5.5 Research and consumables - Market size and forecast 2021-2026
• Exhibit 36: Chart on Research and consumables - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Research and consumables - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Research and consumables - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Research and consumables - Year-over-year growth 2021-2026 (%)

• 5.6 Forensic medicines - Market size and forecast 2021-2026
• Exhibit 40: Chart on Forensic medicines - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Forensic medicines - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Forensic medicines - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Forensic medicines - Year-over-year growth 2021-2026 (%)

• 5.7 Others - Market size and forecast 2021-2026
• Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.8 Market opportunity by Application
• Exhibit 48: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 50: Chart on Market share by geography 2021-2026 (%)
• Exhibit 51: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 90: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 96: Matrix on vendor position and classification

• 10.3 Agilent Technologies Inc.
• Exhibit 97: Agilent Technologies Inc. - Overview
• Exhibit 98: Agilent Technologies Inc. - Business segments
• Exhibit 99: Agilent Technologies Inc. - Key news
• Exhibit 100: Agilent Technologies Inc. - Key offerings
• Exhibit 101: Agilent Technologies Inc. - Segment focus

• 10.4 Bio Rad Laboratories Inc.
• Exhibit 102: Bio Rad Laboratories Inc. - Overview
• Exhibit 103: Bio Rad Laboratories Inc. - Business segments
• Exhibit 104: Bio Rad Laboratories Inc. - Key news
• Exhibit 105: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 106: Bio Rad Laboratories Inc. - Segment focus

• 10.5 BioChain Institute Inc.
• Exhibit 107: BioChain Institute Inc. - Overview
• Exhibit 108: BioChain Institute Inc. - Product / Service
• Exhibit 109: BioChain Institute Inc. - Key offerings

• 10.6 Danaher Corp.
• Exhibit 110: Danaher Corp. - Overview
• Exhibit 111: Danaher Corp. - Business segments
• Exhibit 112: Danaher Corp. - Key news
• Exhibit 113: Danaher Corp. - Key offerings
• Exhibit 114: Danaher Corp. - Segment focus

• 10.7 Fluidigm Corp.
• Exhibit 115: Fluidigm Corp. - Overview
• Exhibit 116: Fluidigm Corp. - Product / Service
• Exhibit 117: Fluidigm Corp. - Key news
• Exhibit 118: Fluidigm Corp. - Key offerings

• 10.8 General Electric Co.
• Exhibit 119: General Electric Co. - Overview
• Exhibit 120: General Electric Co. - Business segments
• Exhibit 121: General Electric Co. - Key news
• Exhibit 122: General Electric Co. - Key offerings
• Exhibit 123: General Electric Co. - Segment focus

• 10.9 Illumina Inc.
• Exhibit 124: Illumina Inc. - Overview
• Exhibit 125: Illumina Inc. - Business segments
• Exhibit 126: Illumina Inc. - Key news
• Exhibit 127: Illumina Inc. - Key offerings
• Exhibit 128: Illumina Inc. - Segment focus

• 10.10 Merck KGaA
• Exhibit 129: Merck KGaA - Overview
• Exhibit 130: Merck KGaA - Business segments
• Exhibit 131: Merck KGaA - Key news
• Exhibit 132: Merck KGaA - Key offerings
• Exhibit 133: Merck KGaA - Segment focus

• 10.11 PerkinElmer Inc.
• Exhibit 134: PerkinElmer Inc. - Overview
• Exhibit 135: PerkinElmer Inc. - Business segments
• Exhibit 136: PerkinElmer Inc. - Key news
• Exhibit 137: PerkinElmer Inc. - Key offerings
• Exhibit 138: PerkinElmer Inc. - Segment focus

• 10.12 Thermo Fisher Scientific Inc.
• Exhibit 139: Thermo Fisher Scientific Inc. - Overview
• Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 141: Thermo Fisher Scientific Inc. - Key news
• Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 144: Inclusions checklist
• Exhibit 145: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 146: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 147: Research methodology
• Exhibit 148: Validation techniques employed for market sizing
• Exhibit 149: Information sources

• 11.5 List of abbreviations
• Exhibit 150: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio